asparagine has been researched along with clioquinol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, H; Choi, KO; Choi, SM; Park, H; Park, YK; Yang, EG | 1 |
1 other study(ies) available for asparagine and clioquinol
Article | Year |
---|---|
Clioquinol, a Cu(II)/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1alpha, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells.
Topics: Asparagine; Carcinoma, Hepatocellular; Cell Hypoxia; Chelating Agents; Clioquinol; Copper; Cyclic AMP Response Element-Binding Protein; Erythropoietin; Humans; Hydroxylation; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoprecipitation; Liver Neoplasms; Neuroblastoma; Oxygen; Peptide Fragments; Procollagen-Proline Dioxygenase; Protein Binding; Protein Processing, Post-Translational; Tumor Cells, Cultured; Ubiquitin; Vascular Endothelial Growth Factor A; Von Hippel-Lindau Tumor Suppressor Protein; Zinc | 2006 |